Biotech · Private company
Otonomy, Inc.
Track this companyFree. Adds Otonomy, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials150 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- 12 mg ciprofloxacinPhase 3 · Acute Otitis ExternaClinicalTrials.gov · fetched Nov 12, 2026
- OTO-104Phase 3 · Meniere DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OTO-104Phase 3 · Meniere's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OTO-201Phase 3 · Bilateral Middle Ear EffusionClinicalTrials.gov · fetched Nov 12, 2026
- OTO-201 (ciprofloxacin)Phase 3 · Otitis MediaClinicalTrials.gov · fetched Nov 12, 2026
- Sham ControlPhase 3 · Acute Otitis ExternaClinicalTrials.gov · fetched Nov 12, 2026
- 12 mg ciprofloxacinPhase 2 · Acute Otitis MediaClinicalTrials.gov · fetched Nov 12, 2026
- 6 mg ciprofloxacinPhase 2 · Acute Otitis MediaClinicalTrials.gov · fetched Nov 12, 2026
- OTO-104Phase 2 · Cisplatin Induced Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
- OTO-201Phase 2 · Acute Otitis MediaClinicalTrials.gov · fetched Nov 12, 2026
- OTO-201 (ciprofloxacin)Phase 2 · Otitis ExternaClinicalTrials.gov · fetched Nov 12, 2026
- OTO-313Phase 2 · Subjective TinnitusClinicalTrials.gov · fetched Nov 12, 2026
- OTO-313Phase 2 · Tinnitus, SubjectiveClinicalTrials.gov · fetched Nov 12, 2026
- OTO-413Phase 2 · Sensorineural Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Acute Otitis MediaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- OTO-313 in Subjects With Unilateral Subjective TinnitusPHASE2 · COMPLETED · started Mar 22, 2021ClinicalTrials.gov NCT04829214 · fetched Nov 12, 2026
- OTO-413 in Subjects With Speech-in-Noise Hearing ImpairmentPHASE1_PHASE2 · COMPLETED · started Oct 1, 2019ClinicalTrials.gov NCT04129775 · fetched Nov 12, 2026
- OTO-313 in Subjects With Subjective TinnitusPHASE1_PHASE2 · COMPLETED · started Apr 4, 2019ClinicalTrials.gov NCT03918109 · fetched Nov 12, 2026
- Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's DiseasePHASE3 · COMPLETED · started Aug 27, 2018ClinicalTrials.gov NCT03664674 · fetched Nov 12, 2026
- Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing LossPHASE2 · TERMINATED · started Nov 15, 2016ClinicalTrials.gov NCT02997189 · fetched Nov 12, 2026
- A 6-Month Extension Study of OTO-104 in Meniere's DiseasePHASE3 · TERMINATED · started Aug 1, 2016ClinicalTrials.gov NCT02768662 · fetched Nov 12, 2026
- Phase 3 Study of OTO-201 in Acute Otitis ExternaPHASE3 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02801370 · fetched Nov 12, 2026
- Study of OTO-104 in Subjects With Unilateral Meniere's DiseasePHASE3 · TERMINATED · started Mar 21, 2016ClinicalTrials.gov NCT02717442 · fetched Nov 12, 2026
- A 6-Month Extension Study of OTO-104 in Meniere's DiseasePHASE3 · TERMINATED · started Feb 1, 2016ClinicalTrials.gov NCT02706730 · fetched Nov 12, 2026
- Dose Ranging Study of OTO-201 in AOMTPHASE2 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02719158 · fetched Nov 12, 2026
- Study of OTO-104 in Subjects With Unilateral Meniere's DiseasePHASE3 · COMPLETED · started Oct 27, 2015ClinicalTrials.gov NCT02612337 · fetched Nov 12, 2026
- Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy TubesPHASE3 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02600559 · fetched Nov 12, 2026
- OTO-201 for the Treatment of Otitis ExternaPHASE2 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02511561 · fetched Nov 12, 2026
- Open-Label Study of OTO-201 for Treatment of AOMTPHASE2 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02408796 · fetched Nov 12, 2026
- Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube AdministrationPHASE3 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02350998 · fetched Nov 12, 2026